ribavirin has been researched along with Lymphoma, B-Cell, Marginal Zone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coskun, A; Karaoglu, AO; Yukselen, O; Yukselen, V | 1 |
Brault, P; Klotz, C; Mallet, V; Pol, S; Sultanik, P | 1 |
Alric, L; Besson, C; Bonnet, D; Cacoub, P; Canioni, D; Davi, F; Hermine, O; Jeannel, J; Lapidus, N; Michot, JM; Pol, S; Rabiega, P; Ysebaert, L | 1 |
Arcaini, L; Bruno, R | 1 |
Brandimarte, G; Torello, M; Tursi, A | 1 |
Andreadis, C; Downs, LH; Miller, WT; Schuster, SJ; Svoboda, J; Tsai, DE | 1 |
2 review(s) available for ribavirin and Lymphoma, B-Cell, Marginal Zone
Article | Year |
---|---|
Lacrimal gland marginal zone lymphoma: regression after treatment of chronic hepatitis C virus infection: case report and review of the literature.
Topics: Adult; Antiviral Agents; Eye Neoplasms; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lacrimal Apparatus; Lymphoma, B-Cell, Marginal Zone; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Ribavirin; Tomography, X-Ray Computed | 2013 |
Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell, Marginal Zone; Ribavirin | 2010 |
1 trial(s) available for ribavirin and Lymphoma, B-Cell, Marginal Zone
Article | Year |
---|---|
Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy.
Topics: Adult; Aged; Antiviral Agents; Female; Gastric Mucosa; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2004 |
3 other study(ies) available for ribavirin and Lymphoma, B-Cell, Marginal Zone
Article | Year |
---|---|
Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment.
Topics: Antiviral Agents; Female; Hepacivirus; Hepatitis C; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Ribavirin; Sofosbuvir; Uridine Monophosphate | 2015 |
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Proportional Hazards Models; Protease Inhibitors; Recombinant Proteins; Ribavirin; RNA, Viral; Survival Rate; Treatment Outcome | 2016 |
Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection.
Topics: Drug Therapy, Combination; Hepatitis C; Humans; Interferons; Liver Neoplasms; Lymphatic Metastasis; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Ribavirin; Salivary Gland Neoplasms | 2005 |